[Skip to the guide](#main) For the conversation before a prescription. [Questions for your visit](/primer-questions#assessment) [Doctors Prescribing Peptides](/) Which doctors prescribe, and on what grounds. Prescribing happens elsewhere. [Page directory](#page-directory) [Start](/) / Visits and costs # What to ask before a prescription Go into the conversation with a health concern, your history and room to ask questions. A proposed prescription is something to discuss, including its costs and what happens next. [The assessment](#assessment) [License checks](#license-checks) [Costs](#costs) [Follow-up](#follow-up) ## Make the reason clear Begin with what brought you to the visit. Describe the change you have noticed or the concern you want assessed. It is fine to bring a medicine name you have heard, then ask how it fits the problem being discussed. Ask for the proposed medicine’s full name and what it is intended to treat. Ask what else could be considered, including an approach without that medicine. Request a reason that makes sense to you, and say when it does not. ### Questions about the decision - What do you think is causing this concern? - What would this treatment aim to change? - What findings support that choice for me? - Could we talk through the other choices? - What else would you need to learn before deciding? A request for a medicine is not enough reason for a doctor to prescribe it. The national organization for state medical boards made this point in its May 2026 guidance. A form needs context The medical boards’ policy says a fixed form you fill out before a visit is not enough for a treatment decision if important health information is missing. The policy can allow an online visit by written questions and answers, with the doctor able to ask for more detail. A live conversation is not always required, but the care still has to meet the usual standards and each state’s rules. [Read the medical boards’ prescribing guidance](https://www.fsmb.org/siteassets/advocacy/policies/guidance-on-recent-trends-in-prescribing-and-dispensing-adopted.pdf) ## Know who is assessing you Before booking a visit, ask which state authorizes the doctor to practice and request their full name. Keep those details with your questions. A clinic name is not the name of the person making the decision. The person assessing you remotely may be described as a clinician, meaning a health professional involved in care. Federal guidance places that visit in your state, based on your physical location during the appointment, so the clinician needs legal permission to practice there. That guidance was checked September 26, 2026. Use the state medical board’s record to check the name, current license status and public disciplinary information. Some states have separate licensing boards for doctors with an MD degree (Doctor of Medicine) and a DO degree (Doctor of Osteopathic Medicine). Ask which degree the doctor holds and which board keeps their license record, so you search the right place. For a remote visit, prepare a place where you can speak and have your notes nearby. Ask what happens if the connection fails, and how to send records the clinician has requested. The medical boards’ policy says a telehealth assessment that needs testing or an in-person examination calls for the doctor to arrange it or refer you. Where the rule comes from Suggested standards from the Federation of State Medical Boards are available for state boards to use. The federation does not grant a national medical license. The enforceable requirements come from each state. [Read federal license guidance](https://telehealth.hhs.gov/licensure/getting-started-licensure) [Open the state board directory](https://www.fsmb.org/contact-a-state-medical-board/) ## Ask for the whole bill Request separate line items for the visit, ongoing care, medicine, tests and delivery. Then ask which parts recur and which are optional. Keep the quote beside the cancellation terms so you can compare the same set of services. Some online weight-care services advertise a membership charge with medicine billed separately, as seen in offers checked September 26, 2026. These were advertised terms on a few pages; they do not set a general market price. An introductory amount can tell you little about the ongoing cost. Ask what you would pay after the offer, whether payment commits you to future months, and what is refundable if the clinician does not prescribe. ### Questions about the bill - What services does this quote cover? - Are medicine and any tests billed separately? - Which amount applies when the promotion ends? - Is any payment refunded when the doctor decides against prescribing? - How is a membership brought to an end? When you speak to the insurer, use the full medicine name and say what condition it would treat. The list your plan uses for drug coverage is called a formulary. Ask whether payment needs the plan’s prior approval, known as prior authorization. The Medicare rules checked September 26, 2026 can allow coverage for a medically accepted use other than weight management, but the plan’s drug list and prior authorization still matter. A limited Medicare payment route For certain weight-management medicines, eligible Part D members have a monthly copay of $50 through the Medicare GLP-1 Bridge. The terms checked September 26, 2026 place the program outside ordinary Part D coverage and keep it running through December 31, 2027. The name GLP-1 refers to a hormone that helps govern blood sugar and appetite. Medicines that copy this hormone’s effects are often called GLP-1 drugs. Adults must be at least 18. Only certain Medicare plans qualify: a stand-alone Part D drug plan, or Medicare Advantage with coordinated care and drug coverage. The program uses the weight and health records from the start of your GLP-1 treatment. BMI, short for body mass index, is a measure calculated from weight and height. A BMI at or above 35 meets the weight test. At a BMI of 30 or more, only specified types of heart failure, hard-to-control blood pressure or kidney disease qualify. At a BMI of 27 or more, the listed conditions are prediabetes, a past heart attack or stroke, or artery disease that causes symptoms. Ask the prescriber to match your recorded diagnoses and their severity to Medicare’s full criteria. A Part D payment for a GLP-1 drug in 2026 rules out Bridge use in 2026; Medicare had not set the 2027 prior-use rule at the September 26, 2026 check. A person being treated for type 2 diabetes goes through regular Part D coverage instead. The Bridge’s $50 payments are left out when Medicare adds up your spending toward Part D’s yearly limit for covered drugs. The Bridge also offers no extra reduction in that copay for people with low incomes, even when they get extra help with ordinary Part D costs. The Bridge requires a prescription and prior authorization. [Read the Medicare Bridge terms](https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge) Request a plan-specific answer before treating an advertised price or a possible benefit as the amount you will pay. ## Agree on what happens next Before leaving the visit, request a copy of the proposed plan. Include the reason for treatment, the product’s name, the next review and how to reach the clinician with questions. Read it once while you still have the chance to ask about unclear words. If a pharmacy would prepare or send the medicine, request its actual name. FDA notes that people obtaining compounded drugs through online platforms may not know which compounder produced them. Check that pharmacy through the licensing board, using FDA’s state-by-state lookup links. A listing confirms a license record; it does not establish that a particular medicine was appropriately dispensed. ### Questions for the next visit - Which pharmacy would fill the prescription? - Who can answer a question about the medicine? - How will we decide whether to continue the plan? - What will be reviewed at the next visit? - If I decide to wait, how can we revisit the choices? Ask about side effects and the response plan for the exact medicine being considered. Request written instructions from the prescribing clinician and dispensing pharmacy, rather than trying to resolve a treatment question from a general web page. A useful finish to the visit is a short explanation you can give in your own words: what is proposed, why it is proposed, and what still needs an answer. [Check the product and evidence](/source-primer) This peptide-care guide puts questions within reach; it offers no clinic visits and sells no medicine. © Doctors Prescribing Peptides. [Read as Markdown](/primer-questions.md) [Text directory](/llms.txt) [Start](/) [Visits & costs](/primer-questions) [Evidence](/source-primer)